share_log

JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $4 Price Target

JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $4 Price Target

JMP Securities重申Benitec Biopharma的市场表现跑赢大盘,维持4美元的目标股价
Benzinga ·  2023/05/18 08:16

JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $4 price target.

JMP Securities分析师Silvan Tuerkcan重申,Benitec Biopharma(纳斯达克股票代码:BNTC)的市场表现跑赢大盘,并维持4美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发